Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Mizuho Analyst Maintains Neutral Rating on Sealed Air with Lowered Price Target

Elaine Mendonca by Elaine Mendonca
February 28, 2024
in Breaking News
0
Finance_ Investing in stocks
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

On February 28, 2024, John Roberts, an analyst at Mizuho, decided to maintain a Neutral rating on Sealed Air (NYSE: SEE) while lowering the price target from $40 to $39. This adjustment stands out among the average outperform rating and price targets between $33 and $54 set by different analysts. It is crucial to highlight that this shift is based on Mizuho’s unique analysis and perspective on Sealed Air’s market performance.

Sealed Air Corporation (SEE) Stock Declines on February 28, 2024: What Investors Need to Know

On February 28, 2024, Sealed Air Corporation (SEE) experienced a decline in its stock performance. According to data from CNN Money, SEE is currently trading near the bottom of its 52-week range and below its 200-day simple moving average. This indicates that the stock may be experiencing some downward pressure.

The price of SEE shares closed at $35.03 on February 28th, which was a decrease of $1.05 or 2.91% from the previous market close. Additionally, in after-hours trading, the stock dropped an additional $0.01. This further decline in price suggests that investors may be selling off their positions in SEE.

Investors should pay attention to price momentum and trends in stock performance. A stock trading near the bottom of its 52-week range and below its 200-day moving average may indicate weakness in the stock’s performance. Investors should consider conducting further research and analysis to determine the underlying reasons for the decline in SEE’s stock price.

Overall, the performance of SEE stock on February 28, 2024, was negative with a significant drop in price. Investors should continue to monitor the stock’s performance and stay informed about any developments that may impact its future price movements.

SEE Corporation Stock Performance Analysis: February 28, 2024

On February 28, 2024, the stock performance of SEE Corporation was closely watched by investors and analysts. The company’s total revenue for the past year was reported at $5.49 billion, which remained flat compared to the previous year. Similarly, the total revenue for the last quarter was $1.38 billion, also holding flat compared to the previous quarter.

However, the net income for the past year was $339.30 million, showing a decrease of 30.94% compared to the previous year. The net income for the last quarter was $124.90 million, which remained flat compared to the previous quarter.

Earnings per share (EPS) for the past year were reported at $2.34, showing a decrease of 29.75% compared to the previous year. On the other hand, the EPS for the last quarter was $0.86, showing an increase of 116.86% compared to the previous quarter.

These financial indicators suggest a mixed performance for SEE Corporation on February 28, 2024. While the total revenue remained flat, the net income showed a decrease compared to the previous year. However, there was a significant increase in EPS compared to the previous quarter.

Investors and analysts will be closely monitoring SEE Corporation’s future performance to assess its financial health and growth prospects. It will be interesting to see how the company navigates through the challenges and opportunities in the market to deliver value to its shareholders.

Tags: SEE
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Financial literacy and school

Analyst Reiterates Buy Rating on Staar Surgical with Lower Price Target

Technology Artificial intelligence Markets and money

C3 AI Reports Strong Financial Results and Industry Expansion in Q3 Fiscal 2024

Mining Markets and money

Foremost Lithiums Proposal for Infrastructure Enhancement in Manitobas Snow Lake Region A Step Towards Sustainable Development

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com